Haleon plc

Haleon plc is a British multinational consumer healthcare company headquartered in Weybridge, England.Haleon has quickly risen to become one of the largest consumer healthcare businesses in the world.

Key Information

• Industry: Healthcare and Consumer Goods
• Headquarters: Weybridge, Surrey, England
• Area Served: Worldwide
• Key People: Dave Lewis (Chairman), Brian McNamara (CEO)
• Products: Oral hygiene and medicines, nutritional products, over-the-counter medicines
• Revenue: £11,302 million (2023)
• Operating Income: £1,996 million (2023)
• Net Income: £1,111 million (2023)
• Total Assets: £34,055 million (2023)
• Total Equity: £16,729 million (2023)
• Number of Employees: 24,000 (2023)

Brands and Products

Haleon's portfolio includes a variety of well-known brands such as:

• Oral Health: Sensodyne, Parodontax, Aquafresh
• Pain Relief: Panadol, Advil
• Vitamins and Supplements: Centrum
• Respiratory and Digestive Products: Theraflu, Tums

Market Presence

Haleon operates with a significant global presence, offering products across 120 markets. The company is a leader in over-the-counter medicines with a 7.3 percent market share.

Governance and Operations

The company's governance is overseen by a Board of Directors responsible for the long-term success of Haleon. The Board delegates specific areas of governance to its Audit & Risk, Environmental & Social Sustainability, Nominations & Governance, and Remuneration Committees.

Commitment to Health

With a purpose to deliver better everyday health with humanity, Haleon's approach combines science, innovation, and human understanding. Their brands are trusted by millions globally, reflecting the company's commitment to improving health and well-being.